|
2024
|
Invention
|
Bispecific proteins. The present invention relates to bispecific molecules for binding to CD80 an... |
|
|
Invention
|
Polypeptides for binding to cd80. The invention relates to antigen binding proteins for binding t... |
|
|
Invention
|
Antibodies for binding to cd80. The invention relates to antigen binding proteins for binding to ... |
|
|
Invention
|
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases.
Disclo... |
|
|
Invention
|
Anti-rhesus d human monoclonal antibodies. The present invention provides for recombinant antibod... |
|
2023
|
Invention
|
Compounds for treating viral infection. The present invention relates generally to a compound and... |
|
|
Invention
|
Cell therapy. The present invention provides for chimeric antigen receptor constructs capable of ... |
|
|
Invention
|
System, method, apparatus and diagnostic test for plasmodium vivax. P. vivax in a subject, and he... |
|
2022
|
Invention
|
Antimalarial agents.
Provided are methods of treating malaria comprising administration of compo... |
|
|
Invention
|
Antimalarial agents. PlasmodiumPlasmodium infection, and for treating malaria. Also provided are ... |
|
|
Invention
|
De-novo designed transmembrane polypeptides and their uses in cellular immunotherapy.
Provided h... |
|
|
Invention
|
Variant ctla4 proteins.
The present application relates to CTLA4 fusion proteins, compositions c... |
|
|
Invention
|
Variant ctla4 proteins. The present application relates to CTLA4 fusion proteins, compositions co... |
|
|
Invention
|
Inhibition of cytokine-induced sh2 protein in nk cells.
The present invention relates to therape... |
|
|
Invention
|
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases. Disclos... |
|
|
Invention
|
Sirna targeting tmprss6 for the treatment of myeloproliferative disorders.
The invention relates... |
|
|
Invention
|
Egfrviii binding proteins.
The present invention relates generally to proteins which bind to hum... |
|
|
Invention
|
Sirna targeting tmprss6 for the treatment of myeloproliferative disorders. The invention relates ... |
|
|
Invention
|
Egfrviii binding proteins. The present invention relates generally to proteins which bind to huma... |
|
|
Invention
|
Inhibition of cytokine-induced sh2 protein in nk cells. The present invention relates to therapeu... |
|
|
Invention
|
Chemovaccination against plasmodium infection with selective plasmepsin x inhibitors.
The presen... |
|
|
Invention
|
Lasmodium infection with selective plasmepsin x inhibitors. Plasmodium Plasmodium infection compr... |
|
|
Invention
|
Sars-cov-2 binding proteins. The present invention relates generally to proteins, such as VHH nan... |
|
|
Invention
|
Insulin analogs. The present invention relates to insulin analogs, particularly insulin analogs h... |
|
2021
|
Invention
|
Antimalarial agents. Provided are methods of treating malaria comprising administration of compou... |
|
|
Invention
|
Methods of chemovaccination against plasmodium infections.
A method of chemovaccination against ... |
|
|
Invention
|
Methods of chemovaccination against plasmodium infections. PlasmodiumPlasmodium infections compri... |
|
|
Invention
|
Serological antibody-based diagnostics of sars-cov-2 infection. The invention relates to composit... |
|
|
Invention
|
De-novo designed transmembrane polypeptides and their uses in cellular immunotherapy. de novo de ... |
|
|
Invention
|
Malaria vaccine and methods for producing same.
The present description relates to malaria vacci... |
|
2020
|
Invention
|
Organoid cultures. The present invention provides improved methods and media for culturing stem c... |
|
|
Invention
|
Antimalarial agents. Plasmodium infection, and for treating malaria. Also provided are methods of... |
|
|
Invention
|
Methods for modulating t cell activation.
The present invention relates to methods, compositions... |
|
2019
|
Invention
|
Methods of treating inflammation.
Methods for treating inflammation, including allergic inflamma... |
|
|
Invention
|
Antimalarial agents. The present invention provides methods of treating malaria comprising admini... |
|
|
Invention
|
Methods of treatment, prevention and diagnosis.
The present invention relates to methods for tre... |
|
|
Invention
|
Parasite vaccine. Toxoplasma’) or a homologue thereof as well as vaccines comprising same. |
|
|
Invention
|
Immunosuppressive glycoforms of soluble cd52.
The present disclosure relates to glycoprotein CD5... |
|
2017
|
Invention
|
Plasmodium vivax. P. vivax in a subject, and hence identify individuals with a high probability o... |
|
2011
|
P/S
|
Lobbying, promoting, publicizing and representing the interests or concerns of others; marketing ... |
